CoChat

The Damaging Effect of Passenger Mutations on Cancer Progression

Open access
McFarland, Christopher D., Yaglom, Julia A., Wojtkowiak, Jonathan W., Scott, Jacob G., Morse, David L., Sherman, Michael Y., Mirny, Leonid A. · 2017 · Cancer Research

Published version of a preprint

Cited by 120

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Genomic instability and high mutation rates cause cancer to acquire numerous mutations and chromosomal alterations during its somatic evolution; most are termed passengers because they do not confer cancer phenotypes. Evolutionary simulations and cancer genomic studies suggest that mildly deleterious passengers accumulate and can collectively slow cancer progression. Clinical data also suggest an association between passenger load and response to therapeutics, yet no causal link between the effects of passengers and cancer progression has been established. To assess this, we introduced increasing passenger loads into human cell lines and immunocompromised mouse models. We found that passengers dramatically reduced proliferative fitness (∼3% per Mb), slowed tumor growth, and reduced metastatic progression. We developed new genomic measures of damaging passenger load that can accurately predict the fitness costs of passengers in cell lines and in human breast cancers. We conclude that genomic instability and an elevated load of DNA alterations in cancer is a double-edged sword: it accelerates the accumulation of adaptive drivers, but incurs a harmful passenger load that can outweigh driver benefit. The effects of passenger alterations on cancer fitness were unrelated to enhanced immunity, as our tests were performed either in cell culture or in immunocompromised animals. Our findings refute traditional paradigms of passengers as neutral events, suggesting that passenger load reduces the fitness of cancer cells and slows or prevents progression of both primary and metastatic disease. The antitumor effects of chemotherapies can in part be due to the induction of genomic instability and increased passenger load. Cancer Res; 77(18); 4763–72. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-15-3283-t

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 38

  1. Castro-giner, 2015, The mini-driver model of polygenic cancer evolution, Nat Rev Cancer, 15, 680, 10.1038/nrc3999 · DOI
  2. Nussinov, 2015, Science Direct “Latent drivers” expand the cancer mutational landscape, Curr Opin Struct Biol, 32, 25, 10.1016/j.sbi.2015.01.004 · DOI
  3. Merlo, 2006, Cancer as an evolutionary and ecological process, Nat Rev Cancer, 6, 924, 10.1038/nrc2013 · DOI · Paper page
  4. Bozic, 2016, Quantifying clonal and subclonal passenger mutations in cancer evolution, PLoS Comput Biol, 12, e1004731, 10.1371/journal.pcbi.1004731 · DOI · Paper page
  5. McFarland, 2013, Impact of deleterious passenger mutations on cancer progression, Proc Natl Acad Sci U S A, 110, 2910, 10.1073/pnas.1213968110 · DOI · Paper page
  6. McFarland, 2014, Tug-of-war between driver and passenger mutations in cancer and other adaptive processes, Proc Natl Acad Sci U S A, 111, 15138, 10.1073/pnas.1404341111 · DOI · Paper page
  7. Gabriel, 1993, Muller's ratchet and mutational meltdowns, Evolution, 47, 1744, 10.1111/j.1558-5646.1993.tb01266.x · DOI · Paper page
  8. Snyder, 2014, Genetic basis for clinical response to CTLA-4 blockade in melanoma, N Engl J Med, 371, 2189, 10.1056/NEJMoa1406498 · DOI · Paper page
  9. Birkbak, 2011, Paradoxical relationship between chromosomal instability and survival outcome in cancer, Cancer Res, 71, 3447, 10.1158/0008-5472.CAN-10-3667 · DOI · Paper page
  10. Sheltzer, 2011, The aneuploidy paradox: costs and benefits of an incorrect karyotype, Trends Genet, 27, 446, 10.1016/j.tig.2011.07.003 · DOI · Paper page
  11. Andor, 2015, Pan-cancer analysis of the extent and consequences of intratumor heterogeneity, Nat Med, 22, 105, 10.1038/nm.3984 · DOI · Paper page
  12. Williams, 2008, Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells, Science, 322, 703, 10.1126/science.1160058 · DOI · Paper page
  13. Weaver, 2007, Aneuploidy acts both oncogenically and as a tumor suppressor, Cancer Cell, 11, 25, 10.1016/j.ccr.2006.12.003 · DOI · Paper page
  14. Schvartzman, 2010, Mitotic chromosomal instability and cancer: mouse modelling of the human disease, Nat Rev Cancer, 10, 102, 10.1038/nrc2781 · DOI · Paper page
  15. Yaglom, 2014, Oncogene-triggered suppression of DNA repair leads to DNA instability in cancer, Oncotarget, 5, 8367, 10.18632/oncotarget.2259 · DOI
  16. Klambauer, 2012, Cn.MOPS: Mixture of Poissons for discovering copy number variations in next-generation sequencing data with a low false discovery rate, Nucleic Acids Res, 40, 1, 10.1093/nar/gks003 · DOI · Paper page
  17. Guberman, 2011, BioMart Central Portal: an open database network for the biological community, Database, 2011, bar041, 10.1093/database/bar041 · DOI · Paper page
  18. Eisenberg, 2013, Human housekeeping genes, revisited, Trends Genet, 29, 569, 10.1016/j.tig.2013.05.010 · DOI · Paper page
  19. Kent, 2002, The human genome browser at UCSC, Genome Res, 12, 996, 10.1101/gr.229102 · DOI · Paper page
  20. Aceto, 2012, Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion, Breast Cancer Res, 14, R131, 10.1186/bcr3329 · DOI
  21. Stephens, 2012, The landscape of cancer genes and mutational processes in breast cancer, Nature, 486, 400, 10.1038/nature11017 · DOI · Paper page
  22. Pedregosa, 2011, Scikit-learn: machine learning in Python, J Mach Learn Res, 12, 2825
  23. Sherman, 2011, Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells, Aging Cell, 10, 949, 10.1111/j.1474-9726.2011.00736.x · DOI
  24. Quiles, 2002, Antioxidant nutrients and adriamycin toxicity, Toxicology, 180, 79, 10.1016/S0300-483X(02)00383-9 · DOI · Paper page
  25. Donahue, 2006, Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability, Proc Natl Acad Sci U S A, 103, 11642, 10.1073/pnas.0510741103 · DOI
  26. Fudenberg, 2011, High order chromatin architecture shapes the landscape of chromosomal alterations in cancer, Nat Biotechnol, 29, 1109, 10.1038/nbt.2049 · DOI · Paper page
  27. Zack, 2013, Pan-cancer patterns of somatic copy number alteration, Nat Genet, 45, 1134, 10.1038/ng.2760 · DOI · Paper page
  28. Carter, 2006, A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers, Nat Genet, 38, 1043, 10.1038/ng1861 · DOI · Paper page
  29. Vermeulen, 2013, Defining stem cell dynamics in models of intestinal tumor initiation, Science, 342, 995, 10.1126/science.1243148 · DOI · Paper page
  30. Duesberg, 2000, Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy, Proc Natl Acad Sci U S A, 97, 14295, 10.1073/pnas.97.26.14295 · DOI · Paper page
  31. Wang, 2012, Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome, Clin Cancer Res, 18, 5806, 10.1158/1078-0432.CCR-12-0857 · DOI · Paper page
  32. Frank, 2007, Dynamics of cancer: Incidence, Inheritance, and Evolution, 10.1515/9780691186863 · DOI · Paper page
  33. Jackson, 1998, The mutation rate and cancer, Genetics, 148, 1483, 10.1093/genetics/148.4.1483 · DOI · Paper page
  34. Charlesworth, 1993, The effect of deleterious mutations on neutral molecular variation, Genetics, 134, 1289, 10.1093/genetics/134.4.1289 · DOI · Paper page
  35. Bachtrog, 2004, Adaptive evolution of asexual populations under Muller's ratchet, Evolution, 58, 1403, 10.1111/j.0014-3820.2004.tb01722.x · DOI
  36. Jordan, 2010, Human allelic variation: perspective from protein function, structure, and evolution, Curr Opin Struct Biol, 20, 342, 10.1016/j.sbi.2010.03.006 · DOI · Paper page
  37. Lee, 2012, Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics, Biochem Pharmacol, 83, 1013, 10.1016/j.bcp.2011.12.008 · DOI
  38. Efron, 1979, Bootstrap methods: another look at the jackknife, Ann Stat, 7, 1, 10.1214/aos/1176344552 · DOI · Paper page

Cited by

See all 120

Metadata

Authors
McFarland, C. D., Yaglom, J. A., Wojtkowiak, J. W., Scott, J. G., Morse, D. L., Sherman, M. Y., & Mirny, L. A.
Venue
Cancer Research
Published
2017-09-14
Volume
77
Issue
18
Pages
4763-4772
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2617489830
Cited by
120
References
10
FWCI
4.26
Type
journal article
Language
en
Open access
green
Funders
  • National Cancer Institute (R01CA176326, U54CA193419)
  • Cancer Systems Biology Scholars (E25CA180993)
  • H. Lee Moffitt Cancer Center and Research Institute (P30-CA076292)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Damaging Effect of Passenger Mutations on Cancer Progression. https://app.cochat.ai/papers/10.1158/0008-5472.can-15-3283-t
The paper
McFarland, C. D., Yaglom, J. A., Wojtkowiak, J. W., Scott, J. G., Morse, D. L., Sherman, M. Y., & Mirny, L. A. (2017). The Damaging Effect of Passenger Mutations on Cancer Progression. Cancer Research. https://doi.org/10.1158/0008-5472.can-15-3283-t

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.